TAIWAN · TWSE / TPEx
TFBS
啟弘生技 · 6939 · Emerging Stock Board · Biotech and medical
Share price, 2026-10-19NT$18.601 month -7.0% · 1 year -21.7%
Directors and supervisors hold10,998,75831.1% of shares issued
Of which pledged0.0%0
Major shareholders (10%+) hold4,942,45514.0% of shares issued
Share price, last 12 months
Daily closes adjusted for cash and stock dividends, against the TAIEX index rebased to the same start. Prices from Yahoo Finance.
Directors, officers and major shareholders
Holdings reported for 2026-09. At election = shares held when the director was elected. Related parties = holdings of the person's spouse, minor children and nominees. One person with two roles is listed once.
| Person | Role | At election | Now | Of the company | Pledged | Related parties |
|---|---|---|---|---|---|---|
| 阮大同 | Chairman · President | 790,857 | 790,857 | 2.24% | — | 765,730 |
| 台康生技股份有限公司 | Director · Major shareholder (10%+) | 4,942,455 | 4,942,455 | 13.97% | — | — |
| 張志榮 | Director (corporate representative) | — | 0 | — | — | — |
| 致茂電子股份有限公司 | Director | 2,675,103 | 2,675,103 | 7.56% | — | — |
| 黃秀妙 | Director (corporate representative) | — | 26,000 | 0.07% | — | — |
| 崇盛投資股份有限公司 | Director | 1,655,680 | 1,655,680 | 4.68% | — | — |
| 呂素卿 | Director (corporate representative) | — | 119,000 | 0.34% | — | — |
| 財團法人生物技術開發中心 | Director | 934,663 | 934,663 | 2.64% | — | — |
| 黃千岳 | Director (corporate representative) | — | 0 | — | — | — |
| 劉永生 | Independent director | — | 0 | — | — | — |
| 林桓志 | Independent director | — | 0 | — | — | — |
| 王柏森 | Independent director | — | 0 | — | — | — |
| 江滿秀 | Vice president | — | 0 | — | — | — |
| 吳沛宇 | Assistant vice president | — | 74,880 | 0.21% | — | — |
| 羅紹華 | Assistant vice president | — | 56,560 | 0.16% | — | 40 |
| 廖秋坤 | Chief financial officer · Chief accountant | — | 2,000 | 0.01% | — | — |